Estimated Average Glucose (eAG) is a vital biomarker offering insights into average blood glucose levels over time. Defined as a calculated estimation derived from Hemoglobin A1c (HbA1c) levels, eAG serves as a pivotal tool for individuals with diabetes, healthcare providers, and those looking to optimize their health.
By delving into what eAG represents, its correlation with HbA1c, and practical applications in clinical settings, this article aims to aid individuals to navigate the complexities of diabetes management effectively.
Estimated Average Glucose (eAG) is a calculated estimate of an individual's average blood glucose levels over a specific period, typically spanning three months. eAG provides a convenient and easily interpretable metric for assessing glycemic control.
Estimated Average Glucose (eAG) is calculated using a mathematical formula based on the correlation between Hemoglobin A1c (HbA1c) levels and average blood glucose concentrations. The formula utilizes established conversion equations to derive an estimated average glucose level in units of milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L) from the HbA1c percentage.
A commonly used formula is (28.7 x HbA1c) - 46.7 for conversion from HbA1c to eAG in mg/dL. [3.]
Estimated Average Glucose (eAG) is derived from the correlation between Hemoglobin A1c (HbA1c) levels and average blood glucose concentrations. HbA1c reflects the percentage of hemoglobin that has become glycated, or bound to glucose molecules, over the lifespan of red blood cells. As blood glucose levels rise, more hemoglobin becomes glycated, resulting in a higher HbA1c percentage.
For every percent increase in HbA1c, the estimated average glucose rises 29 mg/dL. [3.]
Hemoglobin A1c (HbA1c) is a form of hemoglobin in the blood that becomes glycated, or bound to glucose molecules, over time. The percentage of HbA1c in the blood directly correlates with average blood glucose concentrations over the past two to three months.
This correlation serves as the basis for calculating Estimated Average Glucose (eAG), which provides a practical estimation of average blood glucose levels in units of milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).
While HbA1c provides a percentage value indicating average blood glucose levels over the past two to three months, eAG offers a practical estimation of average glucose levels in units of mg/dL or mmol/L.
Together, these metrics provide complementary information, allowing individuals and healthcare providers to monitor glycemic control from different perspectives. This combined approach enhances the interpretation of results and facilitates informed decision-making regarding diabetes management strategies tailored to each individual's unique needs and circumstances.
Consistently elevated glucose levels over time can lead to a cascade of metabolic disturbances including the development of insulin resistance and ultimately, diabetes mellitus.
Chronically high glucose levels are most often associated with poor dietary habits, sedentary lifestyle, or underlying metabolic disorders. Other potential causes include endocrine disorders such as Cushing's syndrome, thyroid problems, PCOS, or acromegaly, which can disrupt glucose metabolism.
Chronically high glucose places excessive demands on the body's insulin-producing pancreatic beta cells. In response to prolonged hyperglycemia, the pancreas secretes higher amounts of insulin to help cells absorb glucose.
However, over time, cells become less responsive to insulin's actions, leading to insulin resistance. This reduced sensitivity of cells to insulin necessitates even higher insulin levels to maintain normal glucose levels, placing further strain on pancreatic function.
Eventually the beta cells may become exhausted, resulting in decreased insulin production and impaired glucose regulation. Insulin resistance coupled with inadequate insulin secretion culminates in persistent hyperglycemia, a hallmark feature of type 2 diabetes mellitus.
Consequently, individuals with chronically high glucose levels are at increased risk of developing insulin resistance, diabetes, and its associated complications.
Healthcare providers recommend specific target ranges for Estimated Average Glucose (eAG) to guide both diabetic and non-diabetic individuals in maintaining optimal glycemic control.
For diabetic individuals, target eAG levels typically correspond to Hemoglobin A1c (HbA1c) percentages within recommended ranges, generally 7% or lower for most adults. This corresponds to an EAG of 154 mg/dL with a range from 123 to 185 mg/dL.
For non-diabetic individuals, target eAG levels may vary based on factors such as age, health status, and individualized goals for maintaining metabolic health. Generally, non-diabetic individuals are advised to aim for eAG levels within a range considered normal for their age and health status, which may fall between 70 to 110 mg/dL or 3.9 to 6.1 mmol/L.
A normal eAG is less than 114 mg/dL which correlates with a HbA1c of 5.6%. eAG levels between 114-137 mg/dL correlate with an HbA1c of 5.6%-6.4%, which is considered prediabetes.
An HbA1c at or above 6.5% corresponds with the diagnosis of diabetes and an eAG level of 140 mg/dL. [2.]
The eAG blood test, primarily derived from Hemoglobin A1c (HbA1c) measurements, involves a straightforward procedure and typically requires minimal preparation.
During the test, a healthcare professional collects a blood sample, usually via venipuncture, from a vein in the arm. Prior to the procedure, individuals are generally advised to fast for at least 8 hours to obtain accurate results, although specific fasting requirements may vary depending on the healthcare provider's instructions. Once the blood sample is collected, it is sent to a laboratory for analysis.
Results are typically available within a few days, allowing individuals and healthcare providers to assess glycemic control and make informed decisions regarding diabetes management strategies.
Diet and lifestyle measures are extremely effective in managing glucose levels and supporting healthy eAG levels over time in nondiabetic patients as well as in the majority of patients diagnosed with type 2 Diabetes.
[1.] A1C and eAG | ADA. diabetes.org. https://diabetes.org/a1c-eag-conversion-calculator
[2.] American Diabetes Association. Diagnosis | ADA. diabetes.org. Published 2023. https://diabetes.org/about-diabetes/diagnosis
[3.] Dib JG. Estimated average glucose: a new term in diabetes control. Ann Saudi Med. 2010 Jan-Feb;30(1):85. doi: 10.4103/0256-4947.59375. PMID: 20103966; PMCID: PMC2850190.
[4.] ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 6. Glycemic Targets: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006. PMID: 36507646; PMCID: PMC9810469.
[5.] Eom YS, Wilson JR, Bernet VJ. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes Metab J. 2022 Mar;46(2):239-256. doi: 10.4093/dmj.2022.0013. Epub 2022 Mar 24. PMID: 35385635; PMCID: PMC8987680.
[6.] Fridman M, Lucas ME, Paprocki Y, Dang-Tan T, Iyer NN. Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis. Clinicoecon Outcomes Res. 2020 Sep 29;12:555-566. doi: 10.2147/CEOR.S266873. PMID: 33061488; PMCID: PMC7535113.
[7.] NIH. Achieving Type 2 Diabetes Remission through Weight Loss | NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. Published 2020. https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/achieving-type-2-diabetes-remission-through-weight-loss
[8.] Riddell M, Perkins BA. Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring. J Diabetes Sci Technol. 2009 Jul 1;3(4):914-23. doi: 10.1177/193229680900300439. PMID: 20144341; PMCID: PMC2769951.
[9.] Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):65-71. PMID: 28539866; PMCID: PMC5426415.
[10.] Sharma K, Akre S, Chakole S, Wanjari MB. Stress-Induced Diabetes: A Review. Cureus. 2022 Sep 13;14(9):e29142. doi: 10.7759/cureus.29142. PMID: 36258973; PMCID: PMC9561544.